Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial
Kathleen N. Moore(University of Oklahoma Health Sciences Center), Angeles Alvarez Secord(Duke University Health System), Melissa A. Geller(University of Minnesota), David S. Miller(The University of Texas Southwestern Medical Center), Noelle Cloven(Texas Oncology), Gini F. Fleming(University of Chicago), Andrea E. Wahner Hendrickson(Mayo Clinic in Arizona), Masoud Azodi(Yale University), Paul DiSilvestro(Providence College), Amit M. Oza(University Health Network), Mihaela Cristea(City Of Hope National Medical Center), Jonathan S. Berek(Cancer Prevention Institute of California), John K. Chan(Sutter Health), B.J. Rimel(Cedars-Sinai Medical Center), Daniela Matei(Northwestern University), Yong Li(Tesaro (United States)), Kaiming Sun(Tesaro (United States)), Katarina Luptakova(Tesaro (United States)), Ursula A. Matulonis(Harvard University), Bradley J. Monk(University of Arizona)
Cited by 531
Abstract
Related Papers
No related papers found
Powered by citation graph analysis